Biohit Oyj Statistics

Total Valuation

Biohit Oyj has a market cap or net worth of EUR 42.96 million. The enterprise value is 36.84 million.

Market Cap	42.96M
Enterprise Value	36.84M

Important Dates

The last earnings date was Wednesday, March 19, 2025.

Earnings Date	Mar 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Biohit Oyj has 15.18 million shares outstanding. The number of shares has increased by 0.59% in one year.

Current Share Class	n/a
Shares Outstanding	15.18M
Shares Change (YoY)	+0.59%
Shares Change (QoQ)	+0.94%
Owned by Insiders (%)	19.73%
Owned by Institutions (%)	0.59%
Float	7.09M

Valuation Ratios

The trailing PE ratio is 16.71 and the forward PE ratio is 18.87.

PE Ratio	16.71
Forward PE	18.87
PS Ratio	3.00
PB Ratio	3.52
P/TBV Ratio	3.67
P/FCF Ratio	233.50
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.71, with an EV/FCF ratio of 200.23.

EV / Earnings	14.35
EV / Sales	2.58
EV / EBITDA	12.71
EV / EBIT	14.41
EV / FCF	200.23

Financial Position

The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.05.

Current Ratio	3.63
Quick Ratio	3.29
Debt / Equity	0.05
Debt / EBITDA	0.20
Debt / FCF	3.19
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 23.76% and return on invested capital (ROIC) is 13.95%.

Return on Equity (ROE)	23.76%
Return on Assets (ROA)	11.25%
Return on Invested Capital (ROIC)	13.95%
Return on Capital Employed (ROCE)	20.48%
Revenue Per Employee	310,500
Profits Per Employee	55,826
Employee Count	46
Asset Turnover	1.01
Inventory Turnover	5.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.50% in the last 52 weeks. The beta is 0.67, so Biohit Oyj's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+41.50%
50-Day Moving Average	2.97
200-Day Moving Average	2.47
Relative Strength Index (RSI)	46.36
Average Volume (20 Days)	5,585

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biohit Oyj had revenue of EUR 14.28 million and earned 2.57 million in profits. Earnings per share was 0.17.

Revenue	14.28M
Gross Profit	9.34M
Operating Income	2.56M
Pretax Income	2.87M
Net Income	2.57M
EBITDA	2.62M
EBIT	2.56M
Earnings Per Share (EPS)	0.17

Full Income Statement

Balance Sheet

The company has 6.71 million in cash and 587,000 in debt, giving a net cash position of 6.12 million or 0.40 per share.

Cash & Cash Equivalents	6.71M
Total Debt	587,000
Net Cash	6.12M
Net Cash Per Share	0.40
Equity (Book Value)	12.19M
Book Value Per Share	0.80
Working Capital	7.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 586,000 and capital expenditures -402,000, giving a free cash flow of 184,000.

Operating Cash Flow	586,000
Capital Expenditures	-402,000
Free Cash Flow	184,000
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 65.39%, with operating and profit margins of 17.90% and 17.98%.

Gross Margin	65.39%
Operating Margin	17.90%
Pretax Margin	20.07%
Profit Margin	17.98%
EBITDA Margin	18.34%
EBIT Margin	17.90%
FCF Margin	1.29%

Dividends & Yields

Biohit Oyj does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.59%
Shareholder Yield	-0.59%
Earnings Yield	5.98%
FCF Yield	0.43%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biohit Oyj has an Altman Z-Score of 8.46.

Altman Z-Score	8.46
Piotroski F-Score	n/a